1. Home
  2. DCO vs PVLA Comparison

DCO vs PVLA Comparison

Compare DCO & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$95.85

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$102.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
PVLA
Founded
1849
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DCO
PVLA
Price
$95.85
$102.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
16
Target Price
$117.80
$141.50
AVG Volume (30 Days)
100.3K
292.1K
Earning Date
11-06-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$806,224,000.00
N/A
Revenue This Year
$6.11
N/A
Revenue Next Year
$8.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.17
N/A
52 Week Low
$51.76
$11.17
52 Week High
$101.47
$114.69

Technical Indicators

Market Signals
Indicator
DCO
PVLA
Relative Strength Index (RSI) 60.22 56.83
Support Level $91.51 $99.00
Resistance Level $99.23 $114.69
Average True Range (ATR) 2.99 8.59
MACD 0.69 0.18
Stochastic Oscillator 78.17 62.78

Price Performance

Historical Comparison
DCO
PVLA

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: